New Olink proteomics services available

Since April 2023, we have extended our Olink proteomics services. Apart from the Olink Explore 384, 1536 and 3072 services, we now also offer the Target 96 and 48 panels, which provide more targeted biomarker analyses.



Now available: MethylationEPIC v2.0 BeadChip

Since the beginning of 2023, a new version of the well-known EPIC array is available. The Infinium MethylationEPIC v2.0 BeadChip builds upon the genome-wide backbone of the MethylationEPIC v1.0, maintaining high backwards compatibility, while adding new content. The Infinium MethylationEPIC v1.0 is no longer available from June 2023 onwards.


New Illumina genotyping arrays

Illumina is introducing a new generation of arrays, which will run on the Excalibur platform. In 2023, two new genotyping arrays with optional enhanced pharmacogenetics will be available, the GSA version 4 and the Global Clinical Research Array (GCRA). In addition, a new methylation array, the Methylation Screening Array (MSA), will be launched that will fit 48 samples and will be run on the same platform.



For more information, please contact dr. Gaby van Dijk.